INCYTE CORPORATION Debt Securities, Available-for-sale, Amortized Cost, Current
INCYTE CORPORATION (INCY) had Debt Securities, Available-for-sale, Amortized Cost, Current of $463.92 million as of 2024-09-30, per its 10-Q filed 2024-10-29.
Financial Statements › Notes › Credit Losses
us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent · last filed 2024-10-29
- 2024-09-30: Debt Securities, Available-for-sale, Amortized Cost, Current $463.92M.
- 2024-06-30: Debt Securities, Available-for-sale, Amortized Cost, Current $464.27M.
- 2024-03-31: Debt Securities, Available-for-sale, Amortized Cost, Current $506.38M.
- 2023-12-31: Debt Securities, Available-for-sale, Amortized Cost, Current $442.82M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost, Current |
|---|---|
| 2024-09-30 | $463.92M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $464.27M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $506.38M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $442.82M 10-Q · filed 2024-10-29 |
| 2023-09-30 | $290.58M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $294.37M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $294.28M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $292.58M 10-K · filed 2024-02-13 |
| 2022-09-30 | $292.94M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $292.35M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $291.61M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $291.87M 10-K · filed 2023-02-07 |
| 2021-09-30 | $285.13M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $283.38M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $292.28M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $288.20M 10-K · filed 2022-02-08 |
| 2020-09-30 | $236.90M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $262.56M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $258.62M 10-Q · filed 2020-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |